RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis - Insciences Organisation

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis Insciences Organisation Pediatric Rheumatology Online Journal. 2005. Vol 3: 2 xi) Long-term efficacy of tocilizumab in rheumatoid arthritis for up to 3.5 years. Smolen J et al. ... Roche: RoActemra Study Shows Efficacy For Juvenile ArthritisWall Street Journal all 5 news articles »

Nearly 75% of Women With Rheumatoid Arthritis Experience Daily Pain - About - News & Issues (blog)

Daily Mail

Nearly 75% of Women With Rheumatoid Arthritis Experience Daily Pain About - News & Issues (blog) Effective treatment for rheumatoid arthritis is for more than symptoms alone -- it's also for the far-reaching consequences of living with the disease. Rheumatoid Arthritis Afflicts Nearly Seventy Five Percent Of Women DailyExaminer.com Rheumatoid arthritis pain reduces productivity, stops patients working and ...PharmiWeb.com (press release) all 153 news articles »

New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ... - MarketWatch (press release)

New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ... MarketWatch (press release) "BMS-945429/ALD518 is one of the first monoclonal antibodies targeted at the IL-6 cytokine to show clinical activity in patients with rheumatoid arthritis, ... Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug TestsWall Street Journal Bristol-Myers says arthritis drug trial met goalReuters RA drug safety trial successfulPharmacy Europe all 116 news articles »

New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... - PR Newswire (press release)

New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... PR Newswire (press release) CELEBREX is currently approved in the US for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis in adults, juvenile rheumatoid ... and more »